Compounds of formula (1) or a pharmaceutically acceptable salt, solvate, acid isostere, or hydrolyzable ester thereof, are disclosed. Methods of making and using the compounds are also disclosed. In particular methods for treating diseases or conditions associated with one or more of human PPAR alpha, gamma, or delta (“hPPARs”) comprising administration of a therapeutically effective amount of a compound of formula (1), are disclosed.
本发明揭示了
化学式(1)或其药学上可接受的盐、溶剂化物、酸同位素或可
水解
酯的化合物。本发明还揭示了制备和使用这些化合物的方法。特别是揭示了治疗与人类
PPAR alpha、gamma或delta(“h
PPARs”)中的一个或多个相关的疾病或病状的方法,包括给予
化学式(1)的化合物的治疗有效量。